Hilma Holm

Title: Hilma Holm: Innovator in Genetic Markers for Cardiac Risk Management

Introduction

Hilma Holm is a prominent inventor based in Mosfellsbaer, Iceland. She has made significant contributions to the field of genetics, particularly in the area of cardiac health. Her innovative work focuses on identifying genetic markers that can help manage the risk of atrial fibrillation and stroke.

Latest Patents

Hilma Holm holds a patent for her invention titled "Genetic markers for risk management of atrial fibrillation and stroke." This invention relates to procedures and methods for determining susceptibility to cardiac arrhythmia, including Atrial Fibrillation, Atrial Flutter, and Stroke. It involves assessing the presence or absence of alleles at polymorphic markers associated with the risk of these conditions. The invention also includes kits that encompass reagents for assessing such markers, along with diagnostic methods and procedures for utilizing these susceptibility markers.

Career Highlights

Hilma Holm is affiliated with Decode Genetics Ehf, a company known for its pioneering work in genetic research. Her role at the company has allowed her to contribute to groundbreaking advancements in understanding genetic predispositions to various health conditions.

Collaborations

Hilma collaborates with Daniel Gudbjartsson, a fellow researcher at Decode Genetics Ehf. Their partnership has been instrumental in advancing the research and development of genetic markers for cardiac health.

Conclusion

Hilma Holm's innovative work in genetic markers for cardiac risk management highlights her significant contributions to medical science. Her patent and ongoing research continue to pave the way for improved diagnostic methods in the field of cardiology.